Praxis Precision Medicines, Inc. Quarterly Return On Equity in % from Q4 2020 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Praxis Precision Medicines, Inc. quarterly/annual Return On Equity history and growth rate from Q4 2020 to Q3 2024.
  • Praxis Precision Medicines, Inc. Return On Equity for the quarter ending September 30, 2024 was -54.9 %, a 66.8% increase year-over-year.
  • Praxis Precision Medicines, Inc. annual Return On Equity for 2023 was -151 %, a 9.83% increase from 2022.
  • Praxis Precision Medicines, Inc. annual Return On Equity for 2022 was -167 %, a 187% decline from 2021.
  • Praxis Precision Medicines, Inc. annual Return On Equity for 2021 was -58.3 %, a 107% decline from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -54.9 +110 +66.8% Jul 1, 2024 Sep 30, 2024
Q2 2024 -61.5 +117 +65.6% Apr 1, 2024 Jun 30, 2024
Q1 2024 -102 +88.1 +46.3% Jan 1, 2024 Mar 31, 2024
Q4 2023 -151 +16.5 +9.83% Oct 1, 2023 Dec 31, 2023
Q3 2023 -165 -30.3 -22.4% Jul 1, 2023 Sep 30, 2023
Q2 2023 -179 -72.7 -68.6% Apr 1, 2023 Jun 30, 2023
Q1 2023 -190 -112 -144% Jan 1, 2023 Mar 31, 2023
Q4 2022 -167 -109 -187% Oct 1, 2022 Dec 31, 2022
Q3 2022 -135 -89.6 -197% Jul 1, 2022 Sep 30, 2022
Q2 2022 -106 -50.6 -91.3% Apr 1, 2022 Jun 30, 2022
Q1 2022 -77.8 +21.5 +21.7% Jan 1, 2022 Mar 31, 2022
Q4 2021 -58.3 -865 -107% Oct 1, 2021 Dec 31, 2021
Q3 2021 -45.4 Jul 1, 2021 Sep 30, 2021
Q2 2021 -55.4 Apr 1, 2021 Jun 30, 2021
Q1 2021 -99.3 Jan 1, 2021 Mar 31, 2021
Q4 2020 807 Oct 1, 2020 Dec 31, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.